Clinical Trial Update: Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immunotherapy combined with chemotherapy in unresectable recurrent loco-regionally advanced nasopharyngeal carcinoma; status not specif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Recurrent Nasopharyngeal Carcinoma, Unresectable Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN